IDXX FY 2022 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

FY 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$3.4B+4.7% YoY

Gross Profit

$2.0B59.5% margin

Operating Income

$899M26.7% margin

Net Income

$679M20.2% margin

EPS (Diluted)

$8.03

Cash Flow

Operating Cash Flow

$543M

Free Cash Flow

$394M

Stock-Based Comp.

$50M

Balance Sheet

Total Assets

$2.7B

Total Liabilities

$2.1B

Stockholders' Equity

$609M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.4B	$3.2B	+4.7%
Gross Profit	$2.0B	$1.9B	+6.1%
Operating Income	$899M	$932M	-3.6%
Net Income	$679M	$745M	-8.8%